Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death.

Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME, Haller M, Riley JS, Mason SM, Athineos D, Parsons MJ, van de Kooij B, Bouchier-Hayes L, Chalmers AJ, Rooswinkel RW, Oberst A, Blyth K, Rehm M, Murphy DJ, Tait SWG. · 2015

Read Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. by Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME, Haller M, Riley JS, Mason SM, Athineos D, Parsons MJ, van de Kooij B, Bouchier-Hayes L, Chalmers AJ, Rooswinkel RW, Oberst A, Blyth K, Rehm M, Murphy DJ, Tait SWG. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4352766.txt.

Introduction

Gabriel Ichim and many co-authors reported in Molecular Cell in 2015 a twist on cell death. In apoptosis, the outer skin of mitochondria opens and releases signals that switch on enzymes called caspases, which kill the cell. That opening was long thought to happen in all mitochondria at once. Using a new imaging method, the team asked whether a small share of mitochondria could open on their own.

A minority of mitochondria did open under stress, a pattern the team names minority MOMP. The caspase activity that followed was too weak to kill the cell. Instead it damaged DNA, and that damage made the genome less stable and pushed cells toward change and tumor growth. So the death pathway can also, when it stays limited, help cancer start.

Catalog record

CREATORIchim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME, Haller M, Riley JS, Mason SM, Athineos D, Parsons MJ, van de Kooij B, Bouchier-Hayes L, Chalmers AJ, Rooswinkel RW, Oberst A, Blyth K, Rehm M, Murphy DJ, Tait SWG.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4352766

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Limited Mitochondrial Permeabilization Causes DNA Damage and Genomic Instability in the Absence of Cell Death By Gabriel Ichim, Jonathan Lopez, Shafiq U. Ahmed, Nathiya Muthalagu, Evangelos Giampazolias, M. Eugenia Delgado, Martina Haller, Joel S. Riley, Susan M. Mason, Dimitris Athineos, Melissa J. Parsons, Bert van de Kooij Published in: Molecular Cell DOI: 10.1016/j.molcel.2015.01.018 ABSTRACT Summary During apoptosis, the mitochondrial outer membrane is permeabilized, leading to the release of cytochrome c that activates downstream caspases. Mitochondrial outer membrane permeabilization (MOMP) has historically been thought to occur synchronously and completely throughout a cell, leading to rapid caspase activation and apoptosis. Using a new imaging approach, we demonstrate that MOMP is not an all-or-nothing event. Rather, we find that a minority of mitochondria can undergo MOMP in a stress-regulated manner, a phenomenon we term “minority MOMP.” Crucially, minority MOMP leads to limited caspase activation, which is insufficient to trigger cell death. Instead, this caspase activity leads to DNA damage that, in turn, promotes genomic instability, cellular transformation, and tumorigenesis. Our data demonstrate that, in contrast to its well-established tumor suppressor function, apoptosis also has oncogenic potential that is regulated by the extent of MOMP. These findings have important implications for oncogenesis following either physiological or therapeutic engagement of apoptosis. INTRODUCTION Following most apoptotic stimuli, the pro-apoptotic BCL-2 family members Bax and Bak permeabilize the outer membrane of the mitochondria, an event termed “mitochondrial outer membrane permeabilization” (MOMP). MOMP leads to rapid cell death by releasing mitochondrial proteins including cytochrome c that activate caspases (Tait and Green, 2010). However, even in the absence of caspase activity, cells typically die once MOMP has occurred, most likely due to progressive mitochondrial dysfunction (Lartigue et al., 2009; Tait et al., 2014). Due to these catastrophic effects, MOMP is often considered the point of no return in the apoptotic program. Mitochondrial apoptosis plays numerous important pathophysiological roles. In cancer, inhibition of apoptosis both promotes tumorigenesis and impedes anti-cancer therapeutic efficacy (Delbridge et al., 2012). Apoptotic inhibition is often achieved by upregulation of anti-apoptotic BCL-2 family members that prevent MOMP. This has led to the development of new anticancer drugs, called BH3-mimetics, which neutralize anti-apoptotic BCL-2 function (Ni Chonghaile and Letai, 2008). Live-cell imaging has demonstrated that mitochondrial permeabilization is often an all-or-nothing event (Goldstein et al., 2000). Widespread mitochondrial permeabilization underpins the lethal effects of MOMP by ensuring robust caspase activity, or in its absence, massive mitochondrial dysfunction. In some limited circumstances, cells can survive MOMP. For example, growth factor-deprived neurons can survive MOMP due to a failure to properly engage caspase activity (Deshmukh and Johnson, 1998; Martinou et al., 1999; Wright et al., 2004). In proliferating cells, expression of the key glycolytic enzyme GAPDH can promote cell survival following MOMP provided caspase activity is inhibited (Colell et al., 2007). We have previously found that the ability of cells to survive MOMP depends on a few mitochondria that evade permeabilization and re-populate the cell (Tait et al., 2010). Whereas earlier studies demonstrated that strong pro-apoptotic stimuli lead to rapid, synchronous, and complete MOMP, technical limitations have made it impossible to study the effects of sub-lethal stresses on individual mitochondria. Here, we use newly developed imaging techniques to demonstrate that MOMP can occur in a limited subset of mitochondria following a sub-lethal stress. Crucially, this limited MOMP leads to caspase activation, which, while insufficient to trigger cell death, leads to limited cleavage of key caspase substrates. This in turn drives DNA-damage and genomic instability, promoting transformation and tumorigenesis. Importantly, our data argue that the mitochondrial apoptotic pathway may exert either a tumor suppressor or oncogenic function depending upon the extent of MOMP. RESULTS Limited Mitochondrial Permeabilization Occurs in the Absence of Cell Death Mitochondrial permeabilization during apoptosis is widespread such that most or all mitochondria within a cell undergo MOMP; this effectively commits a cell to die. However, the potential for sub-lethal apoptotic stresses to engage MOMP in a limited number of mitochondria has not been tested. To investigate this, we used ABT-737, the prototypic BH3-mimetic compound that sensitizes to apoptosis by antagonizing anti-apoptotic BCL-2 family proteins (Oltersdorf et al., 2005). HeLa or U2OS cells were treated with varying concentrations of ABT-737, enantiomer (less-active stereoisomer of ABT-737) or the apoptosis-inducer staurosporine (STS) and analyzed for apoptosis by Annexin V staining and flow cytometry. Importantly, whereas STS triggered apoptosis, treatment with ABT-737 at varying doses failed to induce detectable apoptosis (Figure 1A). Similarly, live-cell imaging using the cell impermeable dye Sytox green also failed to reveal a cytotoxic effect of ABT-737 treatment (Figure S1A). Finally, BH3-mimetic treatment at the indicated doses had no effect on long-term cell survival as determined by clonogenic assay (Figure S1B). We next asked if mitochondrial permeabilization occurred following this non-lethal BH3-mimetic treatment. HeLa cells were treated with ABT-737 or, as a positive control, Actinomycin D (Act D) and cytosolic fractions were probed for the presence of cytochrome c to detect MOMP. As expected, Act D treatment led to MOMP as demonstrated by the detection of cytochrome c in the cytosolic extract (Figure 1B). Surprisingly, treatment with a non-lethal dose of ABT-737 also led to low, but detectable levels of MOMP, implying that MOMP could be engaged without killing the cell (Figure 1B). In caspase-proficient cells, complete MOMP invariably represents a point of no return; we therefore reasoned that MOMP could only be non-lethal if it occurred in a minority of mitochondria (called hereafter minority MOMP). To test this possibility, we developed a new approach to specifically visualize permeabilized mitochondria using fluorescent protein re-localization and chemically dimerizable FKBP/FRB domains (Belshaw et al., 1996). Two fluorescent probes were constructed: a cytosolic probe comprising of GFP fused to a FKBP domain (cytoGFP) and a mitochondrial targeted probe (mitoCherry) comprising of mCherry fused to an FRB domain and the mitochondrial anchoring sequence of Apoptosis Inducing Factor (AIF) (Otera et al., 2005). In the presence of chemical heterodimerizer (A/C heterodimerizer, AP21967), the two probes can only co-localize on mitochondria following MOMP when cytoGFP can gain access to the mitochondrial inner membrane (Figure 1C). To validate this method, we treated U2OS cells with the apoptotic stimulus Act D. Importantly, Act D treatment led to robust mitochondrial re-localization of cytoGFP only in the presence of dimerizer that, as expected, was prevented by blocking MOMP by expression of BCL-xL (Figures 1D, S1C, and S1D). In line with this method marking MOMP as the key initiating apoptotic event, cytoGFP re-localization preceded caspase dependent apoptotic effects including cell shrinkage, rounding, and plasma membrane blebbing (Movie S1). Further verifying this technique, Act D-induced mitochondrial localization of GFP was only observed in cells in which MOMP had occurred, as demonstrated by the cytosolic release of Smac mCherry (a verified reporter of MOMP) (Figure S1E and Movie S2) (Tait et al., 2010). These fluorescent tools thus allow us to detect the permeabilization of individual mitochondria, and thereby assay for the presence of minority MOMP. Using this approach, we investigated the extent of MOMP following sub-lethal apoptotic stimuli. Strikingly, following ABT-737 treatment, we were able detect MOMP in a limited number of mitochondria in both HeLa and U2OS cells (Figure 1E). Confirming their permeabilization, mitochondria with relocalized CytoGFP had also released Smac-mCherry and cytochrome c (Figures S1F and S1G).

Read the complete text